No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs543843383 |
chr11:85335350-85335351 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs565151107 |
chr11:85335354-85335355 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs556305969 |
chr11:85335365-85335366 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs534324630 |
chr11:85335384-85335385 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs145476717 |
chr11:85335387-85335388 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs568146563 |
chr11:85335389-85335390 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs4943925 |
chr11:85335489-85335490 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
8 |
rs148846989 |
chr11:85335492-85335493 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs569413482 |
chr11:85335540-85335541 |
Weak transcription Enhancers
|
CpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs142572693 |
chr11:85335560-85335561 |
Weak transcription Enhancers
|
CpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs188104965 |
chr11:85335570-85335571 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs76474713 |
chr11:85335631-85335632 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs554861736 |
chr11:85335679-85335680 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs538992063 |
chr11:85335701-85335702 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs576753795 |
chr11:85335752-85335753 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs34108115 |
chr11:85335790-85335791 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs544090658 |
chr11:85335811-85335812 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs536849928 |
chr11:85335816-85335817 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs555054976 |
chr11:85335826-85335827 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs576633888 |
chr11:85335890-85335891 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs191233453 |
chr11:85335902-85335903 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs182351517 |
chr11:85335916-85335917 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs553613915 |
chr11:85335917-85335918 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs956202 |
chr11:85335929-85335930 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
25 |
rs146839539 |
chr11:85335974-85335975 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs559607347 |
chr11:85336022-85336023 |
Weak transcription Active TSS Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs574500461 |
chr11:85336032-85336033 |
Weak transcription Active TSS Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs541643493 |
chr11:85336149-85336150 |
Weak transcription Active TSS Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs71684995 |
chr11:85336173-85336174 |
Weak transcription Active TSS Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs10542151 |
chr11:85336175-85336176 |
Weak transcription Active TSS Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs563009145 |
chr11:85336188-85336189 |
Weak transcription Active TSS Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs577279697 |
chr11:85336205-85336206 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs35077682 |
chr11:85336216-85336217 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs374568527 |
chr11:85336217-85336218 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs6592256 |
chr11:85336225-85336226 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
36 |
rs551735360 |
chr11:85336229-85336230 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs563972797 |
chr11:85336240-85336241 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs532832766 |
chr11:85336241-85336242 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs186664012 |
chr11:85336243-85336244 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs566369345 |
chr11:85336285-85336286 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs192330848 |
chr11:85336299-85336300 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs185613050 |
chr11:85336345-85336346 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs140667402 |
chr11:85336353-85336354 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs145860893 |
chr11:85336413-85336414 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs372479397 |
chr11:85336480-85336481 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs11822876 |
chr11:85336486-85336487 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
47 |
rs138475368 |
chr11:85336523-85336524 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs74800899 |
chr11:85336555-85336556 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs141123760 |
chr11:85336557-85336558 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs559728855 |
chr11:85336574-85336575 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|